Monthly Archives: November 2011

Less is More – e-Advocacy in a New Budget Era

Early this fall, I wrote a blog posting on the growing role of e-advocacy.  Notably covered was the growing use of social media not only by members of Congress (virtually all members are using Twitter, YouTube and/or Facebook) as a … Continue reading

Posted in Advocacy, Current Affairs | 1 Comment

FDA Needs to Be Clear About Social Media

After an extended Thanksgiving break, there has been time to contemplate the upcoming end of the year. Two and a half years ago, the FDA stated that “it was not the medium, it was the message” to sum up its … Continue reading

Posted in FDA Image, FDA Policy, New and Social Media | 11 Comments

New Study on U.S. Drug Shortages Calls for Establishment of Early Warning System

For some time now, there have been shortages in the supply of key drugs, many of which have been key treatments for patients undergoing therapy for extremely serious and life-threatening conditions.  The FDA has developed a page on its website … Continue reading

Posted in Current Affairs, FDA Policy | 1 Comment

Weekly Roundup 11/11/11

Our first snow fall is behind us.  The palette of vivid colors that hung on the trees has begun to fade.  The clock has fallen backward, meaning many of us are waking up earlier and tiring more quickly.  It is … Continue reading

Posted in Weekly Roundup | Comments Off

Will Pharma Embrace Google+?

The twittersphere was aflutter with the news yesterday that Google+ was now set up for branded pages.  Until now, Google+ was set up for individuals to use, but companies not so much.  For example, if a company went to set … Continue reading

Posted in New and Social Media | 2 Comments